Trial intelligence / Profile preview

Effect of Sildenafil on the Development of Retinopathy of Prematurity in Preterm Infants

IRCT2015102314215N3Phase 2Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of sildenafil in retinopathy of prematurity (ROP), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Mar 2015; status: completed.

02

Drugs

sildenafil
03

Conditions

retinopathy of prematurity (ROP)

Beyond the preview

Go deeper on IRCT2015102314215N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015102314215N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call